May 9, 2017 / 8:58 PM / 7 months ago

BRIEF-Orexigen Therapeutics reports Q1 loss per share $4.67

May 9 (Reuters) - Orexigen Therapeutics Inc

* Orexigen Therapeutics reports financial results for the first quarter ended March 31, 2017

* Q1 loss per share $4.67

* Q1 revenue $19.1 million

* Orexigen Therapeutics Inc - As of March 31, 2017, Orexigen had $126.6 million in cash, restricted cash and cash equivalents and marketable securities Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below